- Report
In this report, the latest in a quarterly series, CBO highlights its recent work and summarizes its work in progress.
- Report
The federal budget deficit was $1.7 trillion in the first six months of fiscal year 2021, CBO estimates—almost $1 trillion more than the deficit recorded during the same period last year.
- Report
CBO assesses trends in spending for prescription drug research and development (R&D) and the introduction of new prescription drugs. CBO also examines factors that determine how much drug companies spend on R&D.
- Report
CBO describes the key design considerations for a federally administered nongroup health insurance plan—often referred to as a public option—and some of their major implications.
- Cost Estimate
As ordered reported by the House Committee on Transportation and Infrastructure on March 24, 2021
- Cost Estimate
As ordered reported by the House Committee on Foreign Affairs on March 25, 2021
- Cost Estimate
As ordered reported by the Senate Committee on Indian Affairs
on March 24, 2021 - Presentation
Presentation by Jeffrey F. Werling, CBO’s Director of Macroeconomic Analysis, to the Society of Government Economists.
- Cost Estimate
As ordered reported by the House Committee on Foreign Affairs on March 25, 2021
- Cost Estimate
As ordered reported by the House Committee on Foreign Affairs on March 25, 2021
